GW Pharmaceuticals Plc Stock News

Each of these cannabis stocks blazed higher by between 20% and 208% last month.

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for GW Pharmaceuticals Plc's (NASDAQ: GWPH) Epidyolex (cannabidiol). It

– If approved by the European Commission (EC), the label for EPIDYOLEX® will expand to include a third indication in Europe – – If approved by the European Commission (EC), the label for EPIDYO

This month, two groundbreaking deals in cannabis were announced — the acquisition of GW Pharmaceuticals by Jazz Pharmaceuticals and the combination of the multi-state operator (MSO) Parallel with th

Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will c

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

Jazz Pharmaceuticals PLC's (NASDAQ:JAZZ) recently-announced deal to acquire cannabis-derived drug maker GW Pharmaceuticals plc (NASDAQ:GWPH) for US$7.2 billion in cash and stock has boosted investor

The company's net loss was far narrower than many expected.

Interest in cannabis stocks has sparked into life this month as London welcomed its first two specialist medical marijuana companies. A surge in share prices was seen around the world last week, as th

Shares of GW Pharmaceuticals (NASDAQ:GWPH) fell 0.2% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 14.29% year over year to ($0.08), which

Cannabinoid Capital (Podcast Transcript)

NEW YORK, Feb. 12, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class A

The sector is hot again on the heels of two large deals.

Cannabis stocks seem poised to gain on hopes of removal of the federal ban on cannabis products under the new administration.

Cannabinoid Capital (Podcast)